Isabella Alvarez and Daniel Perez (2023) “The Impact of GIP (Gastric Inhibitory Polypeptide) on the Development of Type 2 Diabetes in the Spanish Population: A Longitudinal Study”, Sriwijaya Journal of Internal Medicine, 2(1), pp. 25-36. doi: 10.59345/sjim.v1i2.76.